Leonard Barasa to Enzyme Inhibitors
This is a "connection" page, showing publications Leonard Barasa has written about Enzyme Inhibitors.
Connection Strength
0.415
-
Dawood ZS, Jang A, Mei H, Liggett MR, Wang B, Barasa L, Thompson PR, Couchenour DC, Anand A, Chtraklin K, Liu B, Li Y, Alam HB. Peptidyl arginine deiminase 2 (PAD2) inhibition is associated with acute and long-term benefits in a murine model of traumatic brain injury. J Trauma Acute Care Surg. 2026 Oct 01; 101(4):590-599.
Score: 0.208
-
Rossetti T, Han L, Barasa L, Tran T, Hwang S, O'Reilly M, Xu Z, Thompson PR. Development of Next-Generation Fluoroacetamidine-Containing Activity-Based Probes for the Selective Labeling of the Protein Arginine Deiminases (PADs). ACS Chem Biol. 2026 Jul 17; 21(7):1749-1764.
Score: 0.208